- About Us
- Advisory Board
- Editorial
- Contact Us
- Advertise
- Contact MJH LS
- Do Not Sell My Information
- Terms and Conditions
- Privacy
© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.
Institutional Perspectives in Neurology: Multiple Sclerosis
Takeaways, Highlights From the Institutional Perspectives in Neurology: MS: Eric Klawiter, MD, MSc
February 18, 2022
The director of the Multiple Sclerosis and Neuromyelitis Optica Unit at Massachusetts General Hospital commented on presentations given at the recent event, as well as key takeaways from his own discussion on novel imaging approaches in multiple sclerosis. [WATCH TIME: 2 minutes]
Discussing Novel Imaging Outcomes in Multiple Sclerosis: Eric Klawiter, MD, MSc
February 17, 2022
The director of the Multiple Sclerosis and Neuromyelitis Optica Unit at Massachusetts General Hospital outlined a presentation he gave at a recent Institutional Perspectives in Neurology: MS event. [WATCH TIME: 3 minutes]
Significance and Role of B-Cell Depleting Medications for Multiple Sclerosis
February 17, 2022
Kristin Galetta, MD, MSEd, provided insight on differences between B-cell depleting disease-modifying therapies for MS and how they continue to shape the future of drug development.
Understanding Differences in B-Cell Depleting Medications for MS: Kristin Galetta, MD, MSEd
February 15, 2022
The professor of neurology at Brigham and Women’s Hospital discussed her presentation on B-cell depleting therapies such as ocrelizumab and ofatumumab for the treatment of multiple sclerosis. [WATCH TIME: 2 minutes]
Outlining the Clinical and Radiological Features of NMOSD, MOGAD
December 18, 2021
Amy Kunchok, MD, staff neurologist at the Mellen Center for Multiple Sclerosis and Research at Cleveland Clinic, discussed a recent talk she gave that highlighted the different phenotypes of AQP-IgG NMOSD and MOGAD.
Clinical, Radiological Features of NMOSD and MOGAD: Amy Kunchok, MD
December 16, 2021
The staff neurologist at the Cleveland Clinic Mellen Center for Multiple Sclerosis outlined key findings from her talk at a recent Institutional Perspectives in Neurology: Multiple Sclerosis event. [WATCH TIME: 3 minutes]
Patient Feedback on Telehealth: Marisa McGinley, DO
December 02, 2021
The staff neurologist at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic outlined the positive feedback from patients when discussing telehealth. [WATCH TIME: 4 minutes]
Future Integration, Coverage for Telemedicine in Multiple Sclerosis: Marisa McGinley, DO
December 01, 2021
The staff neurologist at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic discussed the necessary data to support telemedicine’s integration into clinical care. [WATCH TIME: 4 minutes]
Choosing Therapies for Patients With MS: Devon Conway, MD
November 30, 2021
The staff neurologist in the Neurological Institute’s Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic outlined the process of choosing a therapy for patients with multiple sclerosis. [WATCH TIME: 4 minutes]
Choosing Treatments for Patients With Multiple Sclerosis: Devon Conway, MD
November 24, 2021
Discussing newer treatment options in the MS field, the staff neurologist in the Neurological Institute’s Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic noted that patient preference can play a part in the decision-making process. [WATCH TIME: 3 minutes]